Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. [electronic resource]
Producer: 20120820Description: e34443 p. digitalISSN:- 1932-6203
- Amino Acid Sequence
- Animals
- Antineoplastic Agents -- adverse effects
- Calcium -- blood
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Citric Acid -- metabolism
- Down-Regulation -- drug effects
- ErbB Receptors -- metabolism
- Ergocalciferols -- adverse effects
- Fatty Acid Synthases -- metabolism
- Fatty Acids -- biosynthesis
- Female
- Homeostasis -- drug effects
- Humans
- Hypercalcemia -- chemically induced
- L-Lactate Dehydrogenase -- metabolism
- Malonyl Coenzyme A -- biosynthesis
- Membrane Potential, Mitochondrial -- drug effects
- Mice
- Molecular Dynamics Simulation
- Molecular Sequence Data
- Neoplasms, Glandular and Epithelial -- genetics
- Ovarian Neoplasms -- genetics
- Rats
- Receptors, Calcitriol -- antagonists & inhibitors
- Safety
- Signal Transduction -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.